Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway

J Agric Food Chem. 2010 Aug 11;58(15):8643-50. doi: 10.1021/jf101510z.

Abstract

Activation of AMP-activated protein kinase (AMPK), a physiological cellular energy sensor, strongly suppresses cell proliferation in both nonmalignant and tumor cells. This study demonstrates the mechanism of quercetin-induced apoptosis in HT-29 colon cancer cells. Treatment of cells with quercetin significantly decreased cell viability in a dose-dependent manner. Notably, quercetin increased cell cycle arrest in the G1 phase and up-regulated apoptosis-related proteins, such as AMPK, p53, and p21, within 48 h. Furthermore, in vivo experiments showed that quercetin treatment resulted in a significant reduction in tumor volume over 6 weeks, and apoptosis-related protein induction by quercetin was significantly higher in the 100 mg/kg treated group compared to the control group. All of these results indicate that quercetin induces apoptosis via AMPK activation and p53-dependent apoptotic cell death in HT-29 colon cancer cells and that it may be a potential chemopreventive or therapeutic agent against HT-29 colon cancer.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • Apoptosis / drug effects*
  • Cell Cycle / drug effects
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / enzymology
  • Colonic Neoplasms / physiopathology*
  • HT29 Cells
  • Humans
  • Male
  • Mice
  • Mice, Nude
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology
  • Quercetin / administration & dosage
  • Quercetin / pharmacology*
  • Signal Transduction / drug effects*

Substances

  • Plant Extracts
  • Quercetin
  • AMP-Activated Protein Kinases